PHARMA NEWS, MULT...
Follow
Find
82.5K views | +225 today

Almirall's Eduardo Sanchiz and Alfonso Ugarte with their view on patient centricity to pharma - eyeforpharma Barcelona 2016

From www.eyeforpharma.com

In these exclusive videos eyeforpharma's Paul SImms spoke with Eduardo Sanchiz and Alfonso Ugarte, resp CEO and Senior Director of Global Business Units of Almirall, on the changing pharma landscape, patient value and rewriting the business plan.


rob halkes's curator insight, Today, 10:11 AM

Inspiring to see the leadership of Almirall speaking about their personal drives to lead their company to patient centricity.

#Pharma is Not Ready to be Patient Centric, Says This Patient Blogger

From www.linkedin.com

With all due respect, you are not automatically a “patient-centric” company just because you added that term to your marketing materials and hired someone with an eponymous title who travels the country with a spectacular LinkedIn profile on fact-finding missions to buy nonprofit CEO’s lunch to data mine their insights.


And don’t get me started on regulatory. We in the Patient Advocacy sector are not naive to The Physician Payments Sunshine Act. (It just rolls off the tongue, doesn’t it?) This onomatopoeic law is killing all of us. It stifles innovation (with a lower case “i”), presents innumerable encumbrances to actually getting anything done and ties up any possibility for success in a sea of red tape negotiations.


My point is that that a re-imagining of patient-centricity needs to occur STAT. Otherwise no one wins.


PAOs are at fault too. We can’t just take your money and not expect to produce ROI. And yet, there are a few nonprofits for whom ROI is in their DNA. They operate using program management and evidence-based patient outcome reporting. Pharmas that choose to meaningfully engage with these groups benefit from a measurable competitive advantage by viewing us as business partners, rather than charities looking for a handout.

Pharma Guy's curator insight, Today, 10:42 AM

I guess this patient's points are (1) transparency of payments to physicians somehow stifles "innovation," and (2) payments to Patient Advocacy Organizations (PAOs) should be fees for service!

Big data dans la santé avec la big pharma

From www.informatiquenews.fr

Les grandes sociétés de l’IT et de l’internet s’intéressent de très près aux applications du big data dans le domaine de la santé : IBM a signé un partenar
No comment yet.

Digital : le PDG d’Accor crée un Comité exécutif des moins de 35 ans

From www.larevuedudigital.com

A l’heure du digital, il faut absolument écouter les moins de 35 ans. C’est le leitmotiv de Sébastien Bazin, PDG du groupe …
Romain DEFOY's curator insight, February 5, 3:08 AM

 “Les 12 garçons et filles du shadow Comex, le Comex de l’ombre, vont avoir accès à 100% de toutes les informations privilégiées, confidentielles, auxquelles j’ai accès que ce soit sur l’actionnariat, sur les marges, sur les achats, la distribution, tout, 100% de l’agenda qui est le mien, tous les mois,” annonce Sébastien Bazin, PDG du groupe hôtelier Accor.

Quel modèle d'entreprise pour lutter contre l'uberisation ? #pharma #hcsmeufr

From www.fredcavazza.net

La semaine dernière, nous avons encore eu droit à une belle démonstration de violence des chauffeurs de taxi. Une action très spectaculaire, mais bien dérisoire, car s’ils peuvent éventuellement faire pression sur le gouvernement pour... Lire la suite
No comment yet.

Big Pharma spending big to push patients to take their meds

From www.statnews.com

Drug companies around the globe are spending big to push patients to take their pills.

The pharma industry loses tens of billions in worldwide sales each year when patients don’t fill, or refill, their prescriptions.

So drug makers from London to Tokyo to Cambridge, Mass., are pouring money into programs aimed at cajoling — or nagging — patients to take every last pill their doctors prescribe. The companies are investing in smart pills that will send alerts when they haven’t been swallowed at the prescribed time. They’re subsidizing gift cards to thank patients who remember to refill. They’re paying patients to go on talk circuits to tout the virtues of taking medication properly.

No comment yet.

Pharma adoption of social media: A prescription for physician engagement

From www.slideshare.net

DELOITTE : Pharma adoption of social media: A prescription for physician engagement
No comment yet.

3 Reasons Why #Pharma Marketers Are Failing At Social Media #hcsmeufr #hcsmeues

From xtalks.com

While social media has undoubtedly become an integral part of many people’s daily lives, the pharmaceutical industry is lagging when it comes to harnessing the potential power of Twitter and Instagram. Pharma marketers have historically been much more comfortable with the one-sided conversation of a direct-to-consumer (DTC) ad, but as the industry moves more and more towards patient-centricity, it is becoming necessary for drugmakers to increase engagement with their stakeholders.
No comment yet.

Digital Analytics 101 for Healthcare Marketers: SEM and Paid Search

From www.mdconnectinc.com

Across the globe, digital tools are transforming how marketers approach their audiences. But despite this overwhelming consensus, the healthcare industry is often slow to adopt new marketing techniques. As a result, many healthcare professionals are still asking a question that most of us presumed answered a long time ago: “Why digital?”

The reality is that this change in healthcare, as in all industries, is a necessity — the internet is now the primary way that consumers engage with healthcare companies. As John Weston, CMO at Mayo Clinic, explained in a recent AdAge article, “The consumer-to-patient journey is largely a digital journey at their moment of need.” Indeed, at least 72% of Americans look online for health information each year, according to Pew Internet, and that includes medical professionals.

“If I were diagnosed with something tomorrow, one of the first things I would do is go online,” Weston added.

Given how wide this market has become, healthcare marketers must adapt their strategies to better capture and hold the attention of online audiences. But any digital marketing strategy is only as strong as its foundation, which begs the question: where’s the best place to start?

No comment yet.

How pharma can stay competitive in the digital world

From www.mmm-online.com

As drugmakers seek new ways to incorporate digital technology into the way they do business, questions persist about whether the culture at traditional pharma companies is willing to change and move toward digitization.

A report from McKinsey & Company compiled interviews with 20 executives from the analytics, pharmaceutical, provider, technology and venture capital sectors. The overall consensus, the authors of the McKinsey report found, is that the industry needs to transform itself to stay competitive.  

“Successful ones will rethink their business and operating models, transform their cultures and capabilities and adopt a new, longer-term mind-set that fosters innovation and bold strategic moves,” wrote the authors of the report.

It's clear that as the adoption of digital initiatives accelerates, pharma companies will need to experiment more and do so more quickly to respond to the changing behaviors of patients, said Olivier Leclerc, a director at McKinsey.

No comment yet.

Ipsen lance le programme NET Patient Accelerator

From buzz-esante.fr

Pour développer de nouveaux services pour les patients atteints de tumeurs neuroendocrines, le laboratoire Ipsen lance le programme NET Patient Accelerator.
No comment yet.

Creating Better Relationships Through Multichannel Marketing

From digitalblog.exlpharma.com

Finding the way to deliver information in a way your customers will gladly accept.
No comment yet.

LEO Pharma launches new innovation lab with $65M in funding for non-pharmaceutical dermatology expansion

From medcitynews.com

LEO Pharma, which has had a primary focus on skin conditions like psoriasis, has launched its new Innovation Lab to further explore treatment options that don't involve medication.
No comment yet.

5 myths physicians believe about patient experience

From www.advisory.com

See why clinician-patient communication, leadership of the care team, and support and empathy for the patient across the unit are the most important factors for success—and how physicians can embrace the role of
No comment yet.

Digital in 2016

From fr.slideshare.net

We Are Social's comprehensive new Digital in 2016 report presents internet, social media, and mobile usage statistics and trends from all over the world. It co…
No comment yet.

» Communication numérique : Merck, Pfizer et AstraZeneca, « grands leaders » de l’étude Indegene 2016

From www.mypharma-editions.com

Indegene, le groupe indien de solutions santé destinées aux entreprises des sciences du vivant, vient de dévoiler les résultats d'une étude mondiale sur les médecins et leurs habitudes numériques. Cette étude met en avant la combinaison de moyens de contact la plus efficace aux États-Unis, au Japon, en Chine et en Inde. Elle identifie également les sociétés que les professionnels de santé eux-mêmes considèrent comme des leaders.
No comment yet.

Doctors on Twitter: Worldwide growth mapped, 2006-2014

From www.youtube.com

Interactive version now at http://bit.ly/GlobalHCPs Video maps growth in doctors, nurses and healthcare professionals using Twitter since its launch in 2006 ...
Danielle Ralic's comment, January 30, 4:38 AM
Explore the data feature does not work? Would be great to be able to understand what kind of data is behind it and explore some new views.

Pharma Investing Across Digital Health, Biotech...

From www.scoop.it

The number of digital health investments in total was small, with pharma corps with only 28 deals involving pharma corps since 2013.Merck is particularly active in digital health, investing largely through their venture arm in companies including...

No comment yet.

Les big #pharmas stoppent leur stratégie de diversification pour sauver leur croissance #hcsmeufr

From www.latribune.fr

A l'image de Sanofi, les laboratoires pharmaceutiques se séparent de certaine...
No comment yet.

Médicaments : face à la pénurie, le retour en grâce du made in France

From www.lepoint.fr

Des industriels réclament des mesures pour redynamiser l'industrie hexagonale des produits de santé afin de regagner en "souveraineté nationale".
No comment yet.

Big Pharma's bet on Big Data creates opportunities and risks | Reuters

From mobile.reuters.com

Novartis wants every puff of its emphysema drug Onbrez to go into the cloud.
No comment yet.

How the Pharma industry uses Social Media [Infographic]

From hcsmmonitor.com

Research shows Pharma has been slow on the uptake, but massive opportunities await New communications technology has the potential to both disrupt and enha. Marketing topic(s):Social media marketing.

No comment yet.

Pharma companies turn to LinkedIn to engage

From www.mmm-online.com

While the three granddaddy social networks, Facebook, Twitter and YouTube, have spent a decade publicly duking it out for share of human attention-span and
No comment yet.

Baromètre : Les pratiques numériques des médecins généralistes

From m.ipsos.fr

Pour la 2ème année consécutive, Ipsos réalise pour le compte du CESSIM l’étude d’audience et le baromètre digital des professionnels de santé. En 2015, ont été interrogés : les médecins généralistes, les pharmaciens et les spécialistes en dermatologie, neurologie, pédiatrie, rhumatologie et gynécologie.
No comment yet.

Six predictions for pharma and digital health in 2016 – DRG Blog – DRG

From decisionresourcesgroup.com

What will 2016 bring for pharma? Well, the cognoscenti are in consensus that there will be more ugly wrangling over drug prices, but beyond that media...

No comment yet.